ST Elevations in the Era of COVID-19
Título
ST Elevations in the Era of COVID-19
Autor
Charlie Joseph Sang, Brittain Heindl, Gregory Von Mering, Brigitta Brott, Robert S. Kopf, Indranee Rajapreyar
Descripción
Myocardial injury, represented by elevated cardiac enzymes, has been associated with increased morbidity and mortality in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections. Coronavirus disease 2019 (COVID-19) has created unique challenges in approaching patients with acute ST-segment changes. We describe two distinct cases of ST elevation on electrocardiogram occurring in patients with COVID-19 and review important diagnostic and management considerations for the front-line clinician.
Fecha
2020
Identificador
10.1155/2020/8845627
Fuente
Case Reports in Cardiology
Editor
Hindawi Limited
Cobertura
Diseases of the circulatory (Cardiovascular) system
Archivos
Colección
Citación
Charlie Joseph Sang, Brittain Heindl, Gregory Von Mering, Brigitta Brott, Robert S. Kopf, Indranee Rajapreyar, “ST Elevations in the Era of COVID-19,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/5281.
Position: 20117 (13 views)